Literature DB >> 2905981

Current status of beta-blocking drugs in the treatment of anxiety disorders.

P Tyrer1.   

Abstract

beta-Adrenoceptor blocking drugs have been used for the treatment of acute stress reactions, adjustment disorders, generalised anxiety, panic disorder and agoraphobia. In general they are effective in these disorders if somatic or autonomic symptoms are prominent but not extreme in degree. Thus, they are of more value for the relatively mild tremor of the anxious violinist in public performance than in the severe shaking noticed during a panic attack. It is most likely that beta-blockers act primarily by blocking peripheral adrenergic beta-receptors; symptoms that are mediated through beta-stimulation, such as tremor and palpitations, are helped most. Improvement is noted within 1 to 2 hours and with relatively low doses (e.g. propranolol 40 mg/day). Some recent studies, however, have suggested that when longer treatment using higher doses (e.g. propranolol 160 mg/day) is given, improvement in other forms of anxiety is noted after several weeks of treatment. beta-blocking drugs are useful adjuncts to existing treatments for anxiety and are likely to enjoy wider use now that benzodiazepines are being avoided due to their dependence risks.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905981     DOI: 10.2165/00003495-198836060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  52 in total

1.  The influence of propranolol on the exposure in vivo of agoraphobics.

Authors:  J Hafner; F Milton
Journal:  Psychol Med       Date:  1977-08       Impact factor: 7.723

2.  Propranolol in the treatment of anxiety neurosis.

Authors:  V T Tanna; R P Penningroth; R F Woolson
Journal:  Compr Psychiatry       Date:  1977 Jul-Aug       Impact factor: 3.735

3.  Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints.

Authors:  I Nordenfelt; S Persson; A Redfors
Journal:  Acta Med Scand       Date:  1968-12

4.  Drug inhibition of catecholamine-induced metabolic effects in humans.

Authors:  D B Hunninghake; D L Azarnoff; D Waxman
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  Practical aspects of the use of beta-blockers in anxiety states: situational anxiety.

Authors:  I M James
Journal:  Postgrad Med J       Date:  1984       Impact factor: 2.401

6.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

7.  beta-Adrenoreceptor antagonists in essential tremor.

Authors:  D Jefferson; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

8.  Hyperdynamic beta-adrenergic circulatory state.

Authors:  E D Frohlich; H P Dustan; I H Page
Journal:  Arch Intern Med       Date:  1966-05

Review 9.  Drug treatment of social phobia.

Authors:  J M Gorman; L K Gorman
Journal:  J Affect Disord       Date:  1987 Sep-Oct       Impact factor: 4.839

10.  Effect of pindolol on stress-related disturbances of musical performance: preliminary communication.

Authors:  I M James; W Burgoyne; I T Savage
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000

View more
  5 in total

1.  Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin.

Authors:  E A Audi; R M de Oliveira; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Treatment of anxiety.

Authors:  M Lader
Journal:  BMJ       Date:  1994-07-30

3.  Systemic propranolol acts centrally to reduce conditioned fear in rats without impairing extinction.

Authors:  Jose Rodriguez-Romaguera; Francisco Sotres-Bayon; Devin Mueller; Gregory J Quirk
Journal:  Biol Psychiatry       Date:  2009-02-26       Impact factor: 13.382

4.  Propranolol Decreases Fear Expression by Modulating Fear Memory Traces.

Authors:  Sofia Leal Santos; Michelle Stackmann; Andrea Muñoz Zamora; Alessia Mastrodonato; Allegra V De Landri; Nick Vaughan; Briana K Chen; Marcos Lanio; Christine A Denny
Journal:  Biol Psychiatry       Date:  2021-01-20       Impact factor: 12.810

5.  Propranolol Administration Modulates Neural Activity in the Hippocampal Hilus During Fear Retrieval.

Authors:  Sofia Leal Santos; Briana K Chen; Guilherme R Pereira; Vananh Pham; Christine A Denny
Journal:  Front Behav Neurosci       Date:  2022-07-07       Impact factor: 3.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.